APOA1 and hepatocellular carcinoma: The downregulation of APOA1 is linked to increased tumor progression in cancers such as basal-like breast cancer and hepatocellular carcinoma, whereas overexpression of APOA1 has shown anti-proliferative and pro-apoptotic effects [75–77].